• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CYBERONICS, INC. PULSE GEN MODEL 103; GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CYBERONICS, INC. PULSE GEN MODEL 103; GENERATOR Back to Search Results
Model Number 103
Device Problem Device Inoperable (1663)
Patient Problem Seizures (2063)
Event Date 06/11/2015
Event Type  malfunction  
Event Description
Information was received indicating that a vns patient had experienced an increase in seizures and reported that the magnet is not working.A battery life calculation was requested which revealed an expected time of 2.9 years until neos would be reached for the patient's device.Attempts for additional relevant information have been unsuccessful to date.
 
Event Description
Additional information received from the provider indicated that the patient experienced a temporary breakthrough in seizures, attributed the patient's start of menses and birth control medication, on or around (b)(6) 2015.The overall seizure frequency of the breakthrough seizures was back to, but not above, pre-vns level.It was reported that the patient had experienced weight gain (not vns-related) that may have also contributed to the breakthrough seizures in the opinion of the provider.The breakthrough seizures were not related to vns.During the temporary breakthrough seizures the patient experienced one extended duration seizure of 30 min for which the magnet was attempted 14 times but did not abort the seizure.This extended seizure was also attributed to the patient's menses start, birth control medication start with recent weight gain being another possible contributing factor.The extended seizure was not related to vns.On (b)(6) 2015 the patient's vns parameters were changed in an attempt to achieve increased efficacy; normal and magnet output current were each increased one step to 2.25ma and 2.75ma, respectively.Off time was increased from 1.8 min to 3 min.Normal vns function was observed at this visit with diagnostics within normal limits.The provider stated that the patient has not reported any seizures since the (b)(6) visit.It was noted that the patient is on several anti-seizure medications and 2-3 adhd medications and the provider stated belief that birth control medication can negatively impact anti-seizure medication efficacy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE GEN MODEL 103
Type of Device
GENERATOR
Manufacturer (Section D)
CYBERONICS, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
CYBERONICS, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
njemile crawley
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key4916181
MDR Text Key22390343
Report Number1644487-2015-05181
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Report Date 06/19/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/30/2015
Device Model Number103
Device Lot Number3710
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Event Location Other
Date Manufacturer Received07/27/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/21/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age14 YR
-
-